Childhood acute lymphocytic leukemia
Childhood acute lymphocytic leukemia
复制标题
儿童急性淋巴细胞白血病
DOI：
10.3322/canjclin.30.3.158
复制
发表时间：
1980
期刊：
影响因子：
--
通讯作者：
E. Burgert
中科院分区：
文献类型：
--
作者：
W. A. Smithson;G. Gilchrist;E. Burgert
目前，有相当数量的急性淋巴细胞白血病患儿存活时间延长，没有严重后遗症。所有儿童都应在有儿童癌症经验的医生的监督下接受治疗。应适当评估风险因素，并将高风险儿童置于创新方案中。对患者进行长期随访对于尽早发现潜在的禁止性毒性至关重要。
At present, significant numbers of children with ALL enjoy prolonged survival without serious sequelae. All children should be given the benefit of treatment under the supervision of physicians experienced in childhood cancer. Risk factors should be properly assessed and children at high risk placed in innovative programs. Longterm follow-up of patients is essential to detect, as early as possible, potentially prohibitive toxicity.